Stage III Lung Cancer Survivor Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Sex
- Male
- Treatment
- surgery and surveillance
- Outcome
- Survivorship / Surveillance
Treatment course, step by step
- Lung surgery for Stage III cancer left the patient with one lung.
- No additional lung-cancer treatments were named.
- A separate prostate cancer had been present for 2 years, but its treatment was not described.
What happened, in summary
An anonymized 72-year-old man was 5 years beyond surgery for Stage III lung cancer. The operation left him with one lung, yet he was described as breathing normally and remaining able to walk. His lung cancer was in remission. The raw text did not identify the type of lung surgery or name any chemotherapy, radiation or other treatment.
He was also living with controlled hypertension and prediabetes. In addition, he had a separate prostate-cancer history of 2 years. That cancer was asymptomatic and also described as being in remission, although its treatment was not detailed. Keeping the 2 cancers separate is important: the lung operation and single-lung status belonged to the Stage III lung-cancer journey, while the prostate cancer was another primary diagnosis.
His experience was included in a family reflection about the difficulty of rebuilding ordinary routines after cancer enters several parts of life. At the time described, he had moved into survivorship and surveillance rather than active lung-cancer treatment. Living with one lung, other chronic conditions and a second cancer history still required attention, but he remained mobile, breathed normally and had no reported cancer symptoms.
Where this story comes from
This is a lay summary of an account first published by LUNGevity. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer